Richardsons Face Hospitals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 29-12-2024
- Paid Up Capital ₹ 9.85 Cr
as on 29-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.00 Cr
as on 29-12-2024
- Revenue %
(FY 2022)
- Profit -3726.56%
(FY 2022)
- Ebitda -3819.28%
(FY 2022)
- Net Worth 1091.15%
(FY 2022)
- Total Assets 1357.75%
(FY 2022)
About Richardsons Face Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.85 Cr.
The company currently has active open charges totaling ₹8.00 Cr.
Sunil Richardson, Shweta Richardson, and Rajian Asir serve as directors at the Company.
- CIN/LLPIN
U85110KA2020PTC135051
- Company No.
135051
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Richardsons Face Hospitals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Richardson  | Managing Director | 19-Jun-2020 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shweta Richardson | Whole-Time Director | 19-Jun-2020 | Current |
| Rajian Asir | Whole-Time Director | 19-Jun-2020 | Current |
Financial Performance of Richardsons Face Hospitals.
Richardsons Face Hospitals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 3726.56% decrease in profit. The company's net worth Soared by an impressive increase of 1091.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Richardsons Face Hospitals?
In 2022, Richardsons Face Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dhanlaxmi Bank Limited Creation Date: 26 Jul 2023 | ₹8.00 Cr | Open |
How Many Employees Work at Richardsons Face Hospitals?
Richardsons Face Hospitals has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Richardsons Face Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Richardsons Face Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
